Sanofi (SNY) Inventory Average (2018)
Sanofi's (SNY) quarterly Inventory Average came in at $4.3 billion in Q4 2018, up 2723.43% quarter-over-quarter from $153.8 million in Q3 2018.
Analysis
Sanofi (SNY) Inventory Average (2018) Analysis & Trends
Sanofi has disclosed Inventory Average across 1 years of filings, most recently posting $4.3 billion for Q4 2018.
- In Q4 2018, Inventory Average changed N/A year-over-year to $4.3 billion; the TTM figure through Dec 2018 stood at $4.3 billion (changed N/A YoY), while the FY2024 annual figure was $10.3 billion, up 3.84% from the prior year.
- Inventory Average came in at $4.3 billion for Q4 2018 at Sanofi, up from $153.8 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $8.3 billion in Q1 2018 to a low of $153.8 million in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 440.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 4.34 Bn |
| Sep 30, 2018 | 153.79 Mn |
| Jun 30, 2018 | 4.40 Bn |
| Mar 31, 2018 | 8.34 Bn |